BIOMAT Database Logo BIOMAT Database Logo

[Treatment of the malignant phase of infiltrative-edematous exophthalmos in Graves-Basedow disease]. 1984

S Zgliczyński, and T Górowski, and H Jastrzebska, and J Janik, and J Machnicka, and M Ulkowski, and J Kuś, and D Bonisławski

UI MeSH Term Description Entries
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D009915 Orbit Bony cavity that holds the eyeball and its associated tissues and appendages. Eye Socket,Eye Sockets,Orbits,Socket, Eye,Sockets, Eye
D010956 Plasmapheresis Procedure whereby plasma is separated and extracted from anticoagulated whole blood and the red cells retransfused to the donor. Plasmapheresis is also employed for therapeutic use. Double Filtration Plasmapheresis,Therapeutic Immunoadsorption,Therapeutic Plasma Adsorption,Therapeutic Plasmapheresis,Adsorption, Therapeutic Plasma,Adsorptions, Therapeutic Plasma,Double Filtration Plasmaphereses,Filtration Plasmapheresis, Double,Immunoadsorption, Therapeutic,Plasma Adsorption, Therapeutic,Plasmaphereses,Plasmapheresis, Double Filtration,Plasmapheresis, Therapeutic,Therapeutic Immunoadsorptions,Therapeutic Plasma Adsorptions,Therapeutic Plasmaphereses
D011241 Prednisone A synthetic anti-inflammatory glucocorticoid derived from CORTISONE. It is biologically inert and converted to PREDNISOLONE in the liver. Dehydrocortisone,delta-Cortisone,Apo-Prednisone,Cortan,Cortancyl,Cutason,Dacortin,Decortin,Decortisyl,Deltasone,Encorton,Encortone,Enkortolon,Kortancyl,Liquid Pred,Meticorten,Orasone,Panafcort,Panasol,Predni Tablinen,Prednidib,Predniment,Prednison Acsis,Prednison Galen,Prednison Hexal,Pronisone,Rectodelt,Sone,Sterapred,Ultracorten,Winpred,Acsis, Prednison
D003131 Combined Modality Therapy The treatment of a disease or condition by several different means simultaneously or sequentially. Chemoimmunotherapy, RADIOIMMUNOTHERAPY, chemoradiotherapy, cryochemotherapy, and SALVAGE THERAPY are seen most frequently, but their combinations with each other and surgery are also used. Multimodal Treatment,Therapy, Combined Modality,Combined Modality Therapies,Modality Therapies, Combined,Modality Therapy, Combined,Multimodal Treatments,Therapies, Combined Modality,Treatment, Multimodal,Treatments, Multimodal
D004487 Edema Abnormal fluid accumulation in TISSUES or body cavities. Most cases of edema are present under the SKIN in SUBCUTANEOUS TISSUE. Dropsy,Hydrops,Anasarca
D005094 Exophthalmos Abnormal protrusion of both eyes; may be caused by endocrine gland malfunction, malignancy, injury, or paralysis of the extrinsic muscles of the eye. Proptosis,Proptoses
D005260 Female Females
D006111 Graves Disease A common form of hyperthyroidism with a diffuse hyperplastic GOITER. It is an autoimmune disorder that produces antibodies against the THYROID STIMULATING HORMONE RECEPTOR. These autoantibodies activate the TSH receptor, thereby stimulating the THYROID GLAND and hypersecretion of THYROID HORMONES. These autoantibodies can also affect the eyes (GRAVES OPHTHALMOPATHY) and the skin (Graves dermopathy). Basedow's Disease,Exophthalmic Goiter,Goiter, Exophthalmic,Graves' Disease,Basedow Disease,Hyperthyroidism, Autoimmune,Basedows Disease,Disease, Basedow,Disease, Basedow's,Disease, Graves,Disease, Graves',Exophthalmic Goiters,Goiters, Exophthalmic

Related Publications

S Zgliczyński, and T Górowski, and H Jastrzebska, and J Janik, and J Machnicka, and M Ulkowski, and J Kuś, and D Bonisławski
[Ocular hydrodynamics in patients with infiltrative-edematous exophthalmos in Graves' disease].
December 1990, Klinika oczna,
S Zgliczyński, and T Górowski, and H Jastrzebska, and J Janik, and J Machnicka, and M Ulkowski, and J Kuś, and D Bonisławski
[Exophthalmos in Graves-Basedow disease].
January 1955, Revista espanola de oto-neuro-oftalmologia y neurocirugia,
S Zgliczyński, and T Górowski, and H Jastrzebska, and J Janik, and J Machnicka, and M Ulkowski, and J Kuś, and D Bonisławski
[Peribulbar infiltrative changes in Graves-Basedow disease].
August 1975, Klinika oczna,
S Zgliczyński, and T Górowski, and H Jastrzebska, and J Janik, and J Machnicka, and M Ulkowski, and J Kuś, and D Bonisławski
[Exophthalmos in the Graves-Basedow disease; its treatment with ACTH & cortisone].
February 1959, Revista paulista de medicina,
S Zgliczyński, and T Górowski, and H Jastrzebska, and J Janik, and J Machnicka, and M Ulkowski, and J Kuś, and D Bonisławski
[Treatment of malignant edematous exophthalmos].
February 1955, La semaine des hopitaux : organe fonde par l'Association d'enseignement medical des hopitaux de Paris,
S Zgliczyński, and T Górowski, and H Jastrzebska, and J Janik, and J Machnicka, and M Ulkowski, and J Kuś, and D Bonisławski
[Edematous malignant exophthalmos].
October 1955, La semaine des hopitaux : organe fonde par l'Association d'enseignement medical des hopitaux de Paris,
S Zgliczyński, and T Górowski, and H Jastrzebska, and J Janik, and J Machnicka, and M Ulkowski, and J Kuś, and D Bonisławski
[Individual choice of treatment in patients with progressive infiltrative ophthalmopathy in Graves-Basedow disease].
January 1993, Polski tygodnik lekarski (Warsaw, Poland : 1960),
S Zgliczyński, and T Górowski, and H Jastrzebska, and J Janik, and J Machnicka, and M Ulkowski, and J Kuś, and D Bonisławski
[Graves-Basedow disease with symptoms of malignant exophthalmos and the presence of thyroid antibodies in the blood].
January 1970, Endokrynologia Polska,
S Zgliczyński, and T Górowski, and H Jastrzebska, and J Janik, and J Machnicka, and M Ulkowski, and J Kuś, and D Bonisławski
[A case of unilateral exophthalmos with diplopia in Graves-Basedow disease].
January 1962, Endokrynologia Polska,
S Zgliczyński, and T Górowski, and H Jastrzebska, and J Janik, and J Machnicka, and M Ulkowski, and J Kuś, and D Bonisławski
Treatment of Graves-Basedow disease.
June 1947, Prensa medica argentina,
Copied contents to your clipboard!